Preparation and evaluation of biodegradable molecularly imprinted polymers

doi:10.3969/j.issn.2095-4344.2013.38.018

Abstract

Abstract:

BACKGROUND: The cross-linking reagent is the main unit to support the skeleton of molecularly imprinted polymers, which is closely related to the bio-friendly adaption of polymers. The biocompatible and biodegradable capacities of common crosslinking agents are unclear.
OBJECTIVE: To prepare a novel biodegradable molecularly imprinted polymer and to evaluate the adsorption and biodegradability properties of the polymer.
METHODS: The biodegradable molecularly imprinted polymer was synthesized with the acrylated poly ε-caprolactone as the cross-linking reagent under the UV polymerization. The adsorption of the polymer was evaluated by adsorption isotherm, Scatchard analysis and kinetic curves. The biodegradation of the polymer was observed in the simulated physiological environment system in vitro.
RESULTS AND CONCLUSION: Both the molecularly imprinted polymer and non-molecularly imprinted polymer showed an adsorption effect on theophylline, the template. But the adsorption amount of the molecularly imprinted polymer was significantly more than that of the non-molecularly imprinted polymer. The drug loading and encapsulation efficiency of the molecularly imprinted polymer were 1.54% and 12.48%, respectively. The degradation rates of molecularly imprinted polymer and poly(ε-caprolactone) diol were 6.60% and 1.33%, respectively, within the observation time in vitro. The obtained molecularly imprinted polymer not only exhibited specific adsorption to certain molecules but also showed good biodegradable properties in the simulated physiological environment system, which is necessary to be a potent drug carrier.

Key words: biocompatible materials, polymers, biodegradation, environmental, cross-linking reagents

CLC Number:

R318

Li Man, Zhu Quan-hong, Li Min-ting, Wang Wen-na, Dai Jiao-jiao, Yin Yong-guan. Preparation and evaluation of biodegradable molecularly imprinted polymers[J]. Chinese Journal of Tissue Engineering Research, doi: 10.3969/j.issn.2095-4344.2013.38.018.

Figures/Tables 9

References

[1] 王颖,李楠.分子印迹技术及其应用[J].化工进展,2010,29(12): 2315-2323.
[2] 史瑞雪,郭成海,邹小红,等.分子印迹技术研究进展[J].化学进展,2002,14(3):182-191.
[3] 闫有旺,于汝生.分子印迹技术及其应用[J].化学教学,2005,27(4): 28-30.
[4] Puoci F,Cirillo G,Curcio M,et al.Molecularly Imprinted Polymers (MIPs) in Biomedical Applications.Biopolymers. 2010;28:547-574.
[5] Langer R,Peppas NA.Advances in biomaterials, drug delivery, and bionanotechnology.AIChE J.2003;49(12):2990-3006.
[6] 张粉艳,郝红,粱国正.应用于药物控释系统中的生物降解高分子材料[J].离子交换与吸附,2003,19(2):189-192.
[7] Cunliffe D,Kirby A,Alexander C.Molecularly imprinted drug delivery systems.Adv Drug Deliv Rev.2005;57:1836-1853.
[8] 张勇,周建平.分子印迹给药系统研究进展[J].中国药学杂志, 2006, 41(21):1605-1609.
[9] Hilt JZ,Byrne ME.Configurational biomimesis in drug delivery: molecular imprinting of biologically significant molecules.Adv Drug Deliv Rev.2004; 56:1599-1620.
[10] Singh B,Chauhan N.Preliminary evaluation of Molecular Imprinting of 5-fluorouracil within hydrogels for use as drug delivery systems.Acta Biomaterialia.2008;4(5):1244-1254.
[11] Van-nostrum CF.Molecular imprinting：a new tool for drug innovation. Drug Discov Today Technol.2005;2(1):119-124.
[12] Norell MC,Andersson HS,Nicholls IA.Theophylline molecularly imprinted polymer dissociation kinetics: a novel sustained release drug dosage mechanism.J Mol Recognit. 1998;11:98-102.
[13] Cirillo G,Curcio M,Parisi OI,et al. Gastro-intestinal sustained release of phytic acid by molecularly imprinted microparticles. Pharm Dev Technol.2010;15(5):526-531.
[14] Cirillo G,Parisi OI,Curcio M,et al.Molecularly imprinted polymers as drug delivery systems for the sustained release of glycyrrhizic acid.J Pharm Pharmacol.2010;62(5):577-582.
[15] Cirillo G,Iemma F,Puoci F,et al.Imprinted hydrophilic nanospheres as drug delivery systems for 5-fluorouracil sustained release.J Drug Target.2009;17(1):72-77.
[16] Yin J,Cui Y,Yang G,Wang H.Molecularly imprinted nanotubes for enantioselective drug delivery and controlled release.Chem Commun (Camb). 2010;46(41):7688-7690.
[17] Kan X,Geng Z,Zhao Y,et al.Magnetic molecularly imprinted polymer for aspirin recognition and controlled release. Nanotechnology. 2009;20(16):165601.
[18] 凌霞,李红萍,郭娟,等.左旋甲基多巴分子印迹微球给药系统的合成、表征及药物缓释研究[J].化学学报,2010,68(1):95-101.
[19] Jantarat C,Tangthong N,Songkro S,et al.S-Propranolol imprinted polymer nanoparticle-on-microsphere composite porous cellulose membrane for the enantioselectively controlled delivery of racemic propranolol.Int J Pharm. 2008;349:212-215.
[20] Suedee R,Jantarat C,Lindner W,et al.Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs.J Control Release.2010;142(1):122-131.
[21] Suedee R,Bondhibukkana C,Tangthong N,et al.Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.J Control Release. 2008;129(3):170-178.
[22] 王晓青,高永良.手性控释给药系统的研究进展[J].中国医药导刊, 2008,10(3):426-427.
[23] Yañez F,Martikainen L,Braga ME,et al.Supercritical fluid-assisted preparation of imprinted contact lenses for drug delivery.Acta Biomater.2011;7(3):1019-1130.
[24] Ali M,Byrne ME.Controlled release of high molecular weight hyaluronic Acid from molecularly imprinted hydrogel contact lenses.Pharm Res. 2009;26(3):714-726.
[25] Wang C,Javadi A,Ghaffari M,et al. A pH-sensitive molecularly imprinted nanospheres/hydrogel composite as a coating for implantable biosensors. Biomaterials.2010;31(18):4944-4951.
[26] 艾哈麦提•玉素甫,王振斌,朱良.可生物降解材料聚己内酯在医学上的应用进展[J].国外医学:生物医学工程分册,2005,28(1): 19-23.
[27] 宋存先,王彭延,孙洪范,等.聚己内酯在体内的降解、吸收和排泄[J].生物医学工程学杂志,2000,17(1):25-29.
[28] 王永亮,易国斌,康正,等.聚己内酯的合成与应用研究进展[J].化学与生物工程,2006,26(3):1-3.
[29] 刘峰,卓仁禧.水凝胶的制备及应用[J].高分子通报,1995,12(4): 205-216.
[30] 王铁,张黎明.医用高分子水凝胶的设计与合成[J].功能高分子学报,2004,17(2):330-336.
[31] 许志峰,吴双,吴小辉,等.二茂铁甲酸分子印迹聚合物的制备、识别机理和结合特性[J].应用化学,2010,27(4):384-389.
[32] 蒲家志,李丹.非洛地平分子印迹聚合物的制备及其识别特性[J].凯里学院学报,2009,27(3):37-38.
[33] Kweon H,Yoo MK,Park IK,et al.A novel degradable polycaprolactonenetweeks for tissue engineering. Biomaterials. 2003;24:801-808.
[34] Woodward SC,Brewer PS,Moatamed F,et al.The intracellular degradation of poly(ε-caprolactone).J Biomed Mater Res. 1985;19(4):437-444.
[35] Pitt CG,Gratzei MM,Kimmei GL,et al.Aliphatic polyesters Ⅱ: the degradation of poly(DL-lactide),poly(ε-caprolactone), and their copolymers in vivo.Biomaterials.1981;2:215-220.